Measurement of vascular calcification using CT fistulograms

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 484-490

  Toussaint, Nigel D ^a   Lau, Ken K ^a   Polkinghorne, Kevan R ^a   Kerr, Peter G ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Arterio venous fistula; Cardiovascular risk; Computed tomography; End stage renal disease; Haemodialysis; Vascular calcification

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; IOPROMIDE; MINERAL; PHOSPHATE BINDING AGENT;

ADULT; AGED; AORTA; ARTERIOVENOUS FISTULA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FISTULOGRAPHY; HEART MOVEMENT; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; MINERAL METABOLISM; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; SCORING SYSTEM; SUBCLAVIAN VEIN; TREATMENT DURATION;

ADULT; AGED; ANGIOGRAPHY; ARTERIOVENOUS SHUNT, SURGICAL; BRACHIOCEPHALIC TRUNK; BRACHIOCEPHALIC VEINS; CALCINOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846701753     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl621     Document Type: Article

References (24)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119
2. Zoccali C. Cardiovascular risk in uremic patients - is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-457
3. Kalantar-Zadeh K, Block G, Humphries M et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808
4. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998; 31: 607-617
5. London G, Guerin A, Marchais S et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
6. Wong ND, Hsu JC, Detrano RC et al. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000; 86: 495-498
7. Rumberger JA, Brundage BH, Rader DJ et al. Electron beam computed tomographic coronary calcium scanning: A review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999; 74: 243-252
8. Kondos GT, Hoff JA, Sevrukov A et al. Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003; 107: 2571-2576
9. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701
10. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
11. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401
12. Sigrist M, Bungay P, Taal MW et al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714
13. Moe SM, O'Neill KD, Fineberg N et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 2003; 18: 1152-1158
14. Ye C, Mao Z, Rong S et al. Multislice computed tomographic angiography in evaluating dysfunction of the vascular access in hemodialysis patients. Nephron Clin Pract 2006; 104: C94-c100
15. Polkinghorne KR, Yii MK, Yik T et al. Multi-slice CT fistulography: A preliminary comparison to digital subtraction angiography. Nephrology (Carlton) 2006; 11 [Suppl 2]: A30
16. Varley H, Gowenlock AH, Bell M. Calcium, magnesium, phosphorus and phosphates. In: Varley H, Gowenlock AH, Bell M, eds. Practical clinical biochemistry, 5th edn, Heinemann, London, UK: 1980; 850-877
17. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832
18. McIntyre CW. Is it practical to screen dialysis patients for vascular calcification? Nephrol Dial Transplant 2006; 21: 251-254
19. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
20. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
21. Giorcelli G, Tricerri A, Vacha G. 20 years' experience with "difficult" vascular access. Minerva Urol Nefrol 1998; 50: 29-33
22. Milliner DS, Zinsmeister AR, Lieberman E et al. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 1990; 38: 931-936
23. Goldsmith DJ, Covic A, Sambrook PA et al. Vascular calcification in long-term haemodialysis patients in a single unit: A retrospective analysis. Nephron 1997; 77: 37-43
24. Guerin A, London G, Marchais S et al. Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021